| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |